Research ExplorerPublicationsMartini-Klinik experience of prostate cancer surgery during ...

Martini-Klinik experience of prostate cancer surgery during the early phase of the COVID-19 pandemic

Standard

Martini-Klinik experience of prostate cancer surgery during the early phase of the COVID-19 pandemic. / Würnschimmel, Christoph; Maurer, Tobias; Knipper, Sophie; von Breunig, Franziska; Zoellner, Christian; Thederan, Imke; Huland, Hartwig; Graefen, Markus; Michl, Uwe.

In: BJU INT, Vol. 126, No. 2, 08.2020, p. 252-255.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Würnschimmel, C, Maurer, T, Knipper, S, von Breunig, F, Zoellner, C, Thederan, I, Huland, H, Graefen, M & Michl, U 2020, 'Martini-Klinik experience of prostate cancer surgery during the early phase of the COVID-19 pandemic', BJU INT, vol. 126, no. 2, pp. 252-255. https://doi.org/10.1111/bju.15115

APA

Würnschimmel, C., Maurer, T., Knipper, S., von Breunig, F., Zoellner, C., Thederan, I., Huland, H., Graefen, M., & Michl, U. (2020). Martini-Klinik experience of prostate cancer surgery during the early phase of the COVID-19 pandemic. BJU INT, 126(2), 252-255. https://doi.org/10.1111/bju.15115

Vancouver

Würnschimmel C, Maurer T, Knipper S, von Breunig F, Zoellner C, Thederan I et al. Martini-Klinik experience of prostate cancer surgery during the early phase of the COVID-19 pandemic. BJU INT. 2020 Aug;126(2):252-255. https://doi.org/10.1111/bju.15115

Bibtex

@article{cbb96acc7e95467d8d673deff5a28e3e,
title = "Martini-Klinik experience of prostate cancer surgery during the early phase of the COVID-19 pandemic",
abstract = "In order to restrain an uncontrolled spread of the 2019 Coronavirus-Disease (COVID-19) and to provide sufficient intensive-care unit (ICU) capacity, medical specializations needed to develop new routines and risk-strategy protocols. Those restrictions have also impacted the urologic community. Several medical organisations developed specific information-hubs, blogs and resource centers on how to tackle the COVID-19 situation (1-3). Although the German Society of Urology ({"}DGU{"}) has published a recommendation to evaluate the need for a timely therapy in prostate cancer (PCa) patients according to D'Amico risk groups on the 2nd of April 2020, up to now no compulsory directives exist regarding omitting radical prostatectomy (RP) during the COVID-19 pandemic.",
author = "Christoph W{\"u}rnschimmel and Tobias Maurer and Sophie Knipper and {von Breunig}, Franziska and Christian Zoellner and Imke Thederan and Hartwig Huland and Markus Graefen and Uwe Michl",
note = "This article is protected by copyright. All rights reserved.",
year = "2020",
month = aug,
doi = "10.1111/bju.15115",
language = "English",
volume = "126",
pages = "252--255",
journal = "BJU INT",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Martini-Klinik experience of prostate cancer surgery during the early phase of the COVID-19 pandemic

AU - Würnschimmel, Christoph

AU - Maurer, Tobias

AU - Knipper, Sophie

AU - von Breunig, Franziska

AU - Zoellner, Christian

AU - Thederan, Imke

AU - Huland, Hartwig

AU - Graefen, Markus

AU - Michl, Uwe

N1 - This article is protected by copyright. All rights reserved.

PY - 2020/8

Y1 - 2020/8

N2 - In order to restrain an uncontrolled spread of the 2019 Coronavirus-Disease (COVID-19) and to provide sufficient intensive-care unit (ICU) capacity, medical specializations needed to develop new routines and risk-strategy protocols. Those restrictions have also impacted the urologic community. Several medical organisations developed specific information-hubs, blogs and resource centers on how to tackle the COVID-19 situation (1-3). Although the German Society of Urology ("DGU") has published a recommendation to evaluate the need for a timely therapy in prostate cancer (PCa) patients according to D'Amico risk groups on the 2nd of April 2020, up to now no compulsory directives exist regarding omitting radical prostatectomy (RP) during the COVID-19 pandemic.

AB - In order to restrain an uncontrolled spread of the 2019 Coronavirus-Disease (COVID-19) and to provide sufficient intensive-care unit (ICU) capacity, medical specializations needed to develop new routines and risk-strategy protocols. Those restrictions have also impacted the urologic community. Several medical organisations developed specific information-hubs, blogs and resource centers on how to tackle the COVID-19 situation (1-3). Although the German Society of Urology ("DGU") has published a recommendation to evaluate the need for a timely therapy in prostate cancer (PCa) patients according to D'Amico risk groups on the 2nd of April 2020, up to now no compulsory directives exist regarding omitting radical prostatectomy (RP) during the COVID-19 pandemic.

U2 - 10.1111/bju.15115

DO - 10.1111/bju.15115

M3 - SCORING: Journal article

C2 - 32424990

VL - 126

SP - 252

EP - 255

JO - BJU INT

JF - BJU INT

SN - 1464-4096

IS - 2

ER -